Featured
The World Health Organization (WHO) classified the sub-variant
of the Omicron strain JN.1 as a "variant of interest",because of
"its rapidly increasing spread".JN.1 has been found in many countries around the world,
including India, China, UK and the United States.TAKE HOME MESSAGEIt is descended from the BA.2.86 (Pirola) variant.It appears able...
Omicron subvariant XBB.1.16, the strain was first identified in January and has been monitored by the World Health Organisation (WHO) since 22 March, which upgraded it to a “variant of interest” in mid-April.Cases of Omicron variant XBB are mounting in China, forming a new wave expected to crest around 65 million cases...
Nature Medicine and The British Medical Journal (BMJ): Published July, 2022Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection is associated with a range of persistent symptoms impacting everyday
functioning, known as post-COVID-19 condition or long COVID.People experiencing long covid have reported a wider set of
symptoms tha...
The Journal of Dermatology: June, 2022Coronavirus disease 2019 (COVID-19)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
declared a pandemic by the World Health Organization, and COVID-19 continues to
have a major impact on society. Numerous studies have reported
impaired health sequelae after COVID-19 recovery, one...
JAMA Network: November, 2022After the worldwide outbreak
leading to millions of acute cases and thousands of deaths, another important
development is the occurrence or persistence of symptoms after the acute phase
of SARS-CoV-2 infection (ie, long COVID or post–COVID-19).More than 100 post–COVID-19
symptoms affecting multiple systems (eg, cardi...
A new and highly transmissible BF.7 strain of the Omicron
variant has been found to be behind a wider surge of COVID infections in China
and is spreading rapidly around the
world. It has been found in the United States, Denmark, Germany,
France, and India. The highly contagious
new Omicron sub-variant of coronavirus, BF.7, has been detected in...
JAMA Internal Medicine
Ivermectin
treatment during early illness does not prevent progression to severe disease
for high-risk patients with mild-to-moderate COVID-19, according to a study
published online Feb. 18 in JAMA
Internal Medicine.
An in
vitro study demonstrated inhibitory effects of ivermectin against SARS-CoV-2.
Although s...
Journal of the American College of Nutrition:
It is widely recognized that COVID-19 severity is a multifactorial
condition; several risk factors have been identified, including advanced
age, ethnicity, type 2 diabetes, hypertension, obesity, renal dysfunction, and
cardiovascular diseases.
Interestingly, each of these factors
is also...
BMJ: British Medical Journal
This
retrospective case series analysis compared the incidence of immune-mediated
neurologic events among over 8 million individuals vaccinated against COVID-19,
over 700,000 unvaccinated individuals diagnosed with COVID-19, and a historical
cohort of over 14 million individuals in the general population....
JAMA Network:
SARS-CoV-2 continues to infect more
than 22 million patients per week and globally causes more than 65 000 deaths
per week as of January 31, 2022.
Although aspirin has not been shown
to reduce major adverse cardiovascular or pulmonary events in symptomatic
outpatients with COVID-19, several observational studies have fou...
Coronavirus (COVID-19) Vaccine Update:
Take Home Message:
A single booster dose of the Pfizer
COVID-19 vaccine can be given to 5- to 11-year-olds to provide continued
protection against COVID-19., the U.S. Food and Drug Administration announced.
The third shot can be given at
least five months after healthy children complete the two...
European Heart Journal:
Worldwide, survivors of COVID-19
now exceed hundreds of millions, with some reporting incomplete recovery months
beyond the acute illness, a condition commonly referred to as long COVID.
Persistent symptoms of breathlessness, chest pain, fatigue, headaches, brain
fog, and palpitations are a constant reminder of th...
